You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

metastatic pheochromocytoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pheochromocytoma, Metastatic, Pheochromocytoma Malignant, Paraganglioma, Malignant Trial in Beijing (Penpulimab)

Recruiting
  • Pheochromocytoma, Metastatic
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
May 31, 2023

Pheochromocytoma, Metastatic, Paraganglioma, Malignant, Pheochromocytoma Malignant Trial in Beijing (Temozolomide capsule)

Completed
  • Pheochromocytoma, Metastatic
  • +2 more
  • Temozolomide capsule
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
May 4, 2023

Paraganglioma, Pheochromocytoma Trial in New York, Cleveland (Lanreotide)

Recruiting
  • Paraganglioma
  • Pheochromocytoma
  • New York, New York
  • +1 more
Oct 5, 2022

Malignant Adrenal Gland Pheochromocytoma, Malignant Paraganglioma, Pheochromocytoma, Metastatic Trial in Beijing (anlotinib HCl)

Recruiting
  • Malignant Adrenal Gland Pheochromocytoma
  • +4 more
  • anlotinib hydrochloride
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Apr 26, 2022

Neuroblastoma, Pheochromocytoma Trial in New Hyde Park (131-I-meta-iodobenzylguanidine)

Available
  • Neuroblastoma
  • Pheochromocytoma
  • New Hyde Park, New York
    Cohen Children's Medical Center
Apr 4, 2022

Anlotinib Treatment Response Using Contrast Enhanced Ultrasound

Recruiting
  • Pheochromocytoma, Metastatic
  • +3 more
  • Contrast-enhanced ultrasound(CEUS)
  • Beijing, China
    Peking Union Medical College Hospital
Aug 28, 2023

Relapsed Neuroblastoma, Metastatic Pheochromocytoma Trial in Dallas (131 I-Metaiodobenzylguanidine, Potassium Iodide, G-csf)

No longer available
  • Relapsed Neuroblastoma
  • Metastatic Pheochromocytoma
  • 131 I-Metaiodobenzylguanidine
  • +2 more
  • Dallas, Texas
    The University of Texas Southwestern Medical Center
Apr 13, 2022

Relapsed Neuroblastoma, Metastatic Pheochromocytoma Trial in Minneapolis (131 I-Metaiodobenzylguanidine (131I-MIBG), Potassium

Recruiting
  • Relapsed Neuroblastoma
  • Metastatic Pheochromocytoma
  • 131 I-Metaiodobenzylguanidine (131I-MIBG)
  • +3 more
  • Minneapolis, Minnesota
    University of Minnesota Masonic Cancer Center
Jan 20, 2022

Malignant Adrenal Gland Pheochromocytoma, Malignant Paraganglioma, Metastatic Adrenal Gland Pheochromocytoma Trial in Rochester

Completed
Has Results
  • Malignant Adrenal Gland Pheochromocytoma
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Sep 28, 2022

Pheochromocytoma, Paraganglioma Trial in New York (Axitinib)

Recruiting
  • Pheochromocytoma
  • Paraganglioma
  • New York, New York
    Columbia University Irving Medical Center
Oct 5, 2022

Neuroblastoma, Childhood Metastatic Pheochromocytoma Trial in Philadelphia (131 I-Metaiodobenzylguanidine (131 I-MIBG), 131

Available
  • Neuroblastoma
  • Childhood Metastatic Pheochromocytoma
  • 131 I-Metaiodobenzylguanidine (131 I-MIBG)
  • 131 I-MIBG
  • Philadelphia, Pennsylvania
    The Children's Hospital of Philadelphia
Jul 11, 2022

Advanced or Metastatic Paraganglioma/ Pheochromocytoma Trial in Nanjing (Anlotinib)

Recruiting
  • Advanced or Metastatic Paraganglioma/ Pheochromocytoma
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital of Nanjing Medical Univerity
Nov 17, 2021

Adrenocortical Carcinoma, Pheochromocytoma, Paraganglioma Trial in Worldwide (EO2401)

Recruiting
  • Adrenocortical Carcinoma
  • +2 more
  • EO2401
  • Houston, Texas
  • +9 more
Dec 7, 2021

Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor of Pancreas Trial in Iowa City, Rochester

Not yet recruiting
  • Neuroendocrine Tumors
  • +8 more
  • Iowa City, Iowa
  • +1 more
Nov 23, 2022

Locally Advanced Paraganglioma, Metastatic Adrenal Gland Pheochromocytoma, Metastatic Paraganglioma Trial in Houston

Recruiting
  • Locally Advanced Paraganglioma
  • +5 more
  • Cabozantinib S-malate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 7, 2021

Pulmonary Neuroendocrine Tumor, Pheochromocytoma, Paraganglioma Trial in Houston (177Lu-DOTATOC)

Recruiting
  • Pulmonary Neuroendocrine Neoplasm
  • +9 more
  • Houston, Texas
    Excel Diagnostics and Nuclear Oncology Center
Jul 9, 2021

Differentiated Thyroid Gland Carcinoma, Malignant Adrenal Gland Pheochromocytoma, Malignant Paraganglioma Trial in Houston

Active, not recruiting
  • Differentiated Thyroid Gland Carcinoma
  • +3 more
  • Computed Tomography
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 17, 2022

Risk of Metastatic Disease in PPGLs,Retrospective Cohort Study

Not yet recruiting
  • Paraganglioma
  • +6 more
    • Copenhagen, Denmark
    • +1 more
    Mar 9, 2021

    Advanced Adrenal Gland Pheochromocytoma, Advanced Paraganglioma, Metastatic Adrenal Gland Pheochromocytoma Trial in United

    Recruiting
    • Advanced Adrenal Gland Pheochromocytoma
    • +5 more
    • Anchorage, Alaska
    • +153 more
    Aug 23, 2022

    Pheochromocytoma, Endocrine Disease, Endocrine Diseases Trial run by the Eunice Kennedy Shriver National Institute of Child

    Recruiting
    • Pheochromocytoma
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 18, 2023

    Pheochromocytoma, Paraganglioma Trial in Beijing (Temozolomide)

    Recruiting
    • Pheochromocytoma
    • Paraganglioma
    • Beijing, China
      Peking Union Medical College Hospital
    May 22, 2023

    Pheochromocytoma, Paraganglioma, Neuroendocrine Tumors Trial run by the NCI (Lu-177-DOTATATE, Ga-68-DOTATATE, F-18-FDG)

    Recruiting
    • Pheochromocytoma
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 19, 2023

    Recurrent Neuroendocrine Tumor, Metastatic Neuroendocrine Tumor Trial in Cleveland (ONC201)

    Completed
    • Recurrent Neuroendocrine Tumor
    • Metastatic Neuroendocrine Tumor
    • Cleveland, Ohio
      Cleveland Clinic Pediatric and Taussig Cancer Institute, Case Co
    Dec 1, 2022

    Paraganglioma, Pheochromocytoma Trial in Canada, Netherlands (Sunitinib)

    Active, not recruiting
    • Paraganglioma
    • Pheochromocytoma
    • Calgary, Alberta, Canada
    • +3 more
    Nov 29, 2021

    Neuroendocrine Tumor Trial in Beijing (18F-MFBG)

    Recruiting
    • Neuroendocrine Tumor
    • Beijing, Dongcheng, China
      Peking union medical college hospital
    Sep 25, 2021